Literature DB >> 15953820

Is hypercholesterolemia a risk factor for Alzheimer's disease?

W Gibson Wood1, Urule Igbavboa, Gunter P Eckert, Leslie N Johnson-Anuna, Walter E Müller.   

Abstract

There is considerable attention being given to the association of Alzheimer's disease and cholesterol homeostasis. To that end, some have suggested that elevated cholesterol levels are a risk factor for Alzheimer's disease. If elevated cholesterol is a risk factor for Alzheimer's disease, then it would be expected that patients with Alzheimer's disease would have elevated serum and brain cholesterol levels. Studies were reviewed that have examined cholesterol levels in Alzheimer's patients and control subjects, including prospective studies, and based on that review, the conclusion is reached that the majority of studies do not support elevated cholesterol levels in serum and brain as a risk factor for Alzheimer's disease. Alternative hypotheses are discussed, including cholesterol domains and subgroups of individuals with hypercholesteremia.

Entities:  

Mesh:

Year:  2005        PMID: 15953820     DOI: 10.1385/MN:31:1-3:185

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  48 in total

Review 1.  Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond.

Authors:  S I McFarlane; R Muniyappa; R Francisco; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

2.  24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.

Authors:  A Papassotiropoulos; D Lütjohann; M Bagli; S Locatelli; F Jessen; R Buschfort; U Ptok; I Björkhem; K von Bergmann; R Heun
Journal:  J Psychiatr Res       Date:  2002 Jan-Feb       Impact factor: 4.791

Review 3.  Cholesterol, A beta and Alzheimer's disease.

Authors:  T Hartmann
Journal:  Trends Neurosci       Date:  2001-11       Impact factor: 13.837

Review 4.  Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?

Authors:  Makoto Michikawa
Journal:  J Neurosci Res       Date:  2003-04-15       Impact factor: 4.164

5.  Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice.

Authors:  U Igbavboa; N A Avdulov; F Schroeder; W G Wood
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice.

Authors:  Hideki Hayashi; Urule Igbavboa; Hiroki Hamanaka; Mariko Kobayashi; Shinobu C Fujita; W Gibson Wood; Katsuhiko Yanagisawa
Journal:  Neuroreport       Date:  2002-03-25       Impact factor: 1.837

8.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.

Authors:  M Mulder; R Ravid; D F Swaab; E R de Kloet; E D Haasdijk; J Julk; J J van der Boom; L M Havekes
Journal:  Alzheimer Dis Assoc Disord       Date:  1998-09       Impact factor: 2.703

View more
  13 in total

Review 1.  Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date.

Authors:  Allison B Reiss; Elzbieta Wirkowski
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.

Authors:  Chenjia Xu; Liana G Apostolova; Adrian L Oblak; Sujuan Gao
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 4.  Alzheimer's disease and cholesterol: the fat connection.

Authors:  Laura Canevari; John B Clark
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

5.  Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.

Authors:  Gero P Hooff; W Gibson Wood; Ji-Hyun Kim; Urule Igbavboa; Wei-Yi Ong; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-13       Impact factor: 5.590

Review 6.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

Review 7.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

8.  Simvastatin inhibits protein isoprenylation in the brain.

Authors:  Stephen M Ostrowski; Kachael Johnson; Matthew Siefert; Sam Shank; Luigi Sironi; Benjamin Wolozin; Gary E Landreth; Assem G Ziady
Journal:  Neuroscience       Date:  2016-05-12       Impact factor: 3.590

9.  High dietary cholesterol facilitates classical conditioning of the rabbit's nictitating membrane response.

Authors:  Bernard G Schreurs; Carrie A Smith-Bell; Deya S Darwish; Goran Stankovic; D Larry Sparks
Journal:  Nutr Neurosci       Date:  2007 Feb-Apr       Impact factor: 4.994

10.  Novel cerebrovascular pathology in mice fed a high cholesterol diet.

Authors:  Sonia Franciosi; Miguel A Gama Sosa; Daniel F English; Elizabeth Oler; Twethida Oung; William Gm Janssen; Rita De Gasperi; James Schmeidler; Dara L Dickstein; Christoph Schmitz; Sam Gandy; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2009-10-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.